Design and Rationale for the WARFA Trial: A Randomized Controlled Cross-Over Trial Testing the Therapeutic Equivalence of Branded and Generic Warfarin in Atrial Fibrillation Patients in Brazil

BMC Cardiovascular Disorders - United Kingdom
doi 10.1186/s12872-017-0584-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search